These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 3631114)

  • 1. Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction.
    Mathey DG; Sheehan FH; Schofer J; Dodge HT
    J Am Coll Cardiol; 1985 Sep; 6(3):518-25. PubMed ID: 4031265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracoronary urokinase in acute myocardial infarction: prevalence of total coronary occlusion during the early hours, effects on myocardial infarct size and left ventricular function, and outcome of residual coronary stenosis.
    Motomiya T; Tokuyasu Y; Watanabe K; Sakurada H; Ejiri N; Yanase O
    Jpn Circ J; 1988 Jul; 52(7):702-8. PubMed ID: 3184438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late reperfusion for acute myocardial infarction limits the dilatation of left ventricle without the reduction of infarct size.
    Hirayama A; Adachi T; Asada S; Mishima M; Nanto S; Kusuoka H; Yamamoto K; Matsumura Y; Hori M; Inoue M
    Circulation; 1993 Dec; 88(6):2565-74. PubMed ID: 8080490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of intravenous administration of nasaruplase, a plasminogen pro-activator, on left ventricular function and systemic hemodynamics in a canine model of acute myocardial infarction].
    Kido H; Kubo Y; Inoue S; Hayashi K; Narita Y; Uchida T; Watanabe M
    Nihon Yakurigaku Zasshi; 1993 Feb; 101(2):79-91. PubMed ID: 8454229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary thrombolysis with urokinase in acute myocardial infarction. Effects on reperfusion and left ventricular wall motion.
    Cernigliaro C; Sansa M; Campi A; Sante Bongo A; Rossi P
    G Ital Cardiol; 1982; 12(5):365-73. PubMed ID: 6759286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary thrombolysis with intravenous urokinase in patients with acute myocardial infarction.
    Mathey DG; Schofer J; Sheehan FH
    Am J Med; 1987 Aug; 83(2A):26-30. PubMed ID: 3631114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary thrombolysis for evolving myocardial infarction.
    Spann JF; Sherry S
    Drugs; 1984 Nov; 28(5):465-83. PubMed ID: 6391890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of thrombolytic agents on coronary recanalization and patency, cardiac enzyme release, left ventricular function, and mortality in patients with acute myocardial infarction.
    Verstraete M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S38-48. PubMed ID: 2483231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolysis in acute myocardial infarct: prerequisites, current experiences and remaining problems].
    Rapold HJ
    Schweiz Med Wochenschr; 1986 Aug; 116(33):1074-87. PubMed ID: 3094141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of urokinase in the acute phase of myocardial infarction].
    Garnier LF; Gruel Y; François G; Charbonnier B; Brochier M
    Arch Mal Coeur Vaiss; 1987 May; 80(5):591-7. PubMed ID: 3113377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiology and treatment of thrombosis. 3. Prevention and treatment of thrombosis. (1) The role of intracoronary thrombi, platelet function and prostaglandins in the pathogenesis of myocardial infarction; with special reference to intracoronary thrombolysis treatment].
    Kawai C; Yui Y
    Nihon Naika Gakkai Zasshi; 1987 Jan; 76(1):43-8. PubMed ID: 3553380
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.